A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

NCT03222583 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
546
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie